← All trials
NCT03754387
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2019
- Primary completion
- Jan 1, 2021
- Completion date
- Jan 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zunyi Medical CollegeLead sponsor
- Guizhou Medical UniversityStudy director
- Zunyi Medical CollegeReponsible party - principal investigator
- Zunyi Medical CollegeStudy director
- people hospital of SuiyangStudy director
- Children's hospital of guiyangStudy director
- Children's hospital of DalianStudy director
- Zunyi Medical CollegeStudy chair
- Binzhou Medical UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.